Germany C-Reactive Protein Testing Market Size & Outlook
The c-reactive protein testing market in Germany is expected to reach a projected revenue of US$ 322.3 million by 2033. A compound annual growth rate of 1.8% is expected of Germany c-reactive protein testing market from 2026 to 2033.
Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian
Other key industry trends
In terms of revenue, Germany accounted for 5.2% of the global c-reactive protein testing market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany c-reactive protein testing market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 263.8 million by 2033.
Germany accounted for the highest share in the European market in 2020 and is expected to grow further over the forecast period. This can be attributed to factors such as ongoing investigations, favorable regulatory policies, and rising incidence of various inflammatory disorders.
Moreover, increase in support by various organizations such as German Centre for Cardiovascular Research (DZHK) and WHO for development of novel CRP testing devices is expected to boost the market growth.
In addition, various investigations in the field of cancer & cardiovascular disorders are also expected to drive further progressions in the CRP testing market. According to Robert Koch Institute in Germany, each year, 480,000 people are diagnosed with cancer, which increases the need for rapid diagnostics.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to C-reactive Protein Testing Market Outlook will help companies and investors design strategic landscapes.
Immunoturbidimetric Assay was the largest segment with a revenue share of 49.23% in 2025.
Horizon Databook has segmented the Germany c-reactive protein testing market based on immunoturbidimetric assay, elisa, chemiluminescence immunoassay (clia ) covering the revenue growth of each sub-segment from 2021 to 2033.
Germany accounted for the highest share in the European market in 2020 and is expected to grow further over the forecast period. This can be attributed to factors such as ongoing investigations, favorable regulatory policies, and rising incidence of various inflammatory disorders.
Moreover, increase in support by various organizations such as German Centre for Cardiovascular Research (DZHK) and WHO for development of novel CRP testing devices is expected to boost the market growth.
In addition, various investigations in the field of cancer & cardiovascular disorders are also expected to drive further progressions in the CRP testing market. According to Robert Koch Institute in Germany, each year, 480,000 people are diagnosed with cancer, which increases the need for rapid diagnostics.
Germany C-Reactive Protein Testing Market Assay Type Outlook (Revenue, USD Million , 2021-2033)
Immunoturbidimetric assay
ELISA
Chemiluminescence Immunoassay (CLIA )
Others
Germany C-Reactive Protein Testing Market Detection range Outlook (Revenue, USD Million , 2021-2033)
hs-CRP
Conventional CRP
cCRP
Germany C-Reactive Protein Testing Market Disease type Outlook (Revenue, USD Million , 2021-2033)
Cardiovascular Diseases
Cancer
Rheumatoid arthritis
Inflammatory bowel disease
Endometriosis
Lupus
Others
Germany C-Reactive Protein Testing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Clinics
Hospitals
Laboratories
Assisted Living Healthcare Facilities
Home
Others
Reasons to subscribe to C-reactive Protein Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of C-reactive Protein Testing Market Outlook databook
Our clientele includes a mix of C-reactive Protein Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany C-reactive Protein Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany C-reactive Protein Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Germany C-Reactive Protein Testing Market, 2021-2033 (US$M)